The system by which Germany's 110,000 panel doctors operating within the public-sector health fund framework run their practice budgets is to be revamped. Their federation, the KBV, says the new system will avoid a further "drastic" rise in the volume of treatments booked for fund reimbursement.
The date for the reform is not yet clear, with the KBV board favoring January 1997 and the doctors' representatives preferring July 1997. The final decision will be made by a committee of panel doctors and health funds.
The new system will extend the controversial unified system of treatment and cost evaluation which the KBV launched in January, and is a departure from the KBV's existing fees policy. The practice budgets will provide each doctor, independent of speciality or patient numbers, with an upper limit on the treatments and services to be provided with reimbursement. Any extra services will not be funded. In first-quarter 1996, the panel doctors undertook 30%-40% more treatments and services than in first-half 1995.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze